Keywords: encouraging, data, bayer, bay, 43-9006, melanoma, pharmaceuticals

Encouraging data for Bayer's BAY 43-9006 in melanoma

Article | 14 June 2004

Bayer Pharmaceuticals Corp, the US unit of Germany's Bayer Healthcare, and Onyx Pharmaceutical have announced encouraging interim results from a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in